Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: A meta-analysis

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Li, Ya ^a,b   Shi, Bingyin ^a   Li, Sheli ^b  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b YAN'AN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHEMERIN; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CHEMERIN PROTEIN, HUMAN; CHEMOKINE; SIGNAL PEPTIDE;

ARTICLE; BODY FAT; BODY MASS; CLINICAL INDICATOR; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE MARKER; HUMAN; METABOLIC SYNDROME X; OBESITY; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BLOOD; INSULIN RESISTANCE; META ANALYSIS; METABOLISM; PATHOLOGY;

BODY MASS INDEX; C-REACTIVE PROTEIN; CHEMOKINES; CHOLESTEROL; DIABETES MELLITUS; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; METABOLIC SYNDROME X; OBESITY; TRIGLYCERIDES;

EID: 84916223955     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113915     Document Type: Article

References (31)

1. Ford ES, Li C, Zhao G (2010) Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US. J Diabetes 2: 180-193.
2. Song SH, Fukui K, Nakajima K, Kozakai T, Sasaki S, et al. (2010) Cloning, expression analysis, and regulatory mechanisms of bovine chemerin and chemerin receptor. Domestic animal endocrinology 39: 97-105.
3. Zabel BA, Allen SJ, Kulig P, Allen JA, Cichy J, et al. (2005) Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. The Journal of biological chemistry 280: 34661-34666.
4. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, et al. (2007) Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148: 4687-4694.
5. Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, et al. (2007) Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. The Journal of biological chemistry 282: 28175-28188.
6. Fatima SS, Bozaoglu K, Rehman R, Alam F, Memon AS (2013) Elevated chemerin levels in Pakistani men: an interrelation with metabolic syndrome phenotypes. PloS one 8: e57113.
7. Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, et al. (2010) Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. The Journal of clinical endocrinology and metabolism 95: 2892-2896.
8. Ress C, Tschoner A, Engl J, Klaus A, Tilg H, et al. (2010) Effect of bariatric surgery on circulating Chemerin levels. European journal of clinical investigation 40: 277-280.
9. Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, et al. (2009) Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. The Journal of clinical endocrinology and metabolism 94: 3085-3088.
10. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, et al. (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. The Journal of experimental medicine 198: 977-985.
11. Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, et al. (2010) Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clinical endocrinology 72: 342-348.
12. Lehrke M, Becker A, Greif M, Stark R, Laubender RP, et al. (2009) Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. European journal of endocrinology/European Federation of Endocrine Societies 161: 339-344.
13. Alfadda AA, Sallam RM, Chishti MA, Moustafa AS, Fatma S, et al. (2012) Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: adipose depot specificity and gender dimorphism. Molecules and cells 33: 591-596.
14. Wang LY, Wei L, Yu HY, Zhang Y, Jia WP (2009) Relationship of serum chemerin to obesity and type 2 diabetes mellitus. Zhonghua yi xue za zhi 89: 235-238.
15. Kim SH, Lee SH, Ahn KY, Lee DH, Suh YJ, et al. (2014) Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes. Clinical Clin Endocrinol (Oxf) 80: 825-833.
16. Chu SH, Lee MK, Ahn KY, Im JA, Park MS, et al. (2012) Chemerin and adiponectin contribute reciprocally to metabolic syndrome. PloS one 7: e34710.
17. Jialal I, Devaraj S, Kaur H, Adams-Huet B, Bremer AA (2013) Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. The Journal of clinical endocrinology and metabolism 98: E514-517.
18. Stefanov T, Bluher M, Vekova A, Bonova I, Tzvetkov S, et al. (2013) Circulating chemerin decreases in response to a combined strength and endurance training. Endocrine 45: 382-391.
19. Rupinski MT, Dunlap WP (1996) Approximating pearson product-moment correlations from Kennall's tau and Spearman's rho. Educ. Psychol. Measur 56: 419-429.
20. Wilson DB, Lipsey MW (2001) The role of method in treatment effectiveness research: evidence from meta-analysis. Psychological methods 6: 413-429.
21. Higgins J, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Statistics in medicine 21: 1539-1558.
22. Higgins JP, Thompson SG (2004) Controlling the risk of spurious findings from meta-regression. Stat Med 23: 1663-1682.
23. Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, et al. (2010) Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 95: 2892-2896.
24. Tan BK, Chen J, Farhatullah S, Adya R, Kaur J, et al. (2009) Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes 58: 1971-1977.
25. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, et al. (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. The Journal of experimental medicine 201: 713-722.
26. Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, et al. (2008) Synthetic chemerin-derived peptides suppress inflammation through ChemR23. The Journal of experimental medicine 205: 767-775.
27. Stejskal D, Karpisek M, Hanulova Z, Svestak M (2008) Chemerin is an independent marker of the metabolic syndrome in a Caucasian population-a pilot study. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 152: 217-221.
28. Takahashi M, Takahashi Y, Takahashi K, Zolotaryov FN, Hong KS, et al. (2008) Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS letters 582: 573-578.
29. Takahashi M, Inomata S, Okimura Y, Iguchi G, Fukuoka H, et al. (2013) Decreased serum chemerin levels in male Japanese patients. Endocrine Journal 60: 37-44.
30. Coimbra S, Proença JB, Santos-Silva A, Neuparth MJ (2014) Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: a close linkage with obesity and length of the disease. BioMed Research International Article ID 701915.
31. Coory MD (2010) Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified. International journal of epidemiology 39: 932; author reply 933.